CIBC Private Wealth Group’s Neos Therapeutics, Inc NEOS Stock Holding History

CIBC Private Wealth Group’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-15,335	Closed	-$10K	–	1085
2020 Q4	$10K	Hold	15,335	–	–	﹤0.01%	972
2020 Q3	$8K	Buy	+15,335	New	+$10.4K	﹤0.01%	875
2020 Q2	–	Sell	-15,335	Closed	-$12K	–	855
2020 Q1	$12K	Hold	15,335	–	–	﹤0.01%	834
2019 Q4	$23K	Hold	15,335	–	–	﹤0.01%	892
2019 Q3	$23K	Hold	15,335	–	–	﹤0.01%	882
2019 Q2	$20K	Hold	15,335	–	–	﹤0.01%	910
2019 Q1	$40K	Hold	15,335	–	–	﹤0.01%	914
2018 Q4	$25K	Hold	15,335	–	–	﹤0.01%	861
2018 Q3	$74K	Buy	15,335 +1,852	+14%	+$10.5K	﹤0.01%	941
2018 Q2	$84K	Hold	13,483	–	–	﹤0.01%	1061
2018 Q1	$112K	Hold	13,483	–	–	﹤0.01%	999
2017 Q4	$138K	Hold	13,483	–	–	﹤0.01%	986
2017 Q3	$123K	Buy	+13,483	New	+$102K	﹤0.01%	907

CIBC Private Wealth Group's NEOS Position: Q1 2021 in Review

CIBC Private Wealth Group sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 15,335 shares — an estimated $10K sold.

CIBC Private Wealth Group first reported a position in NEOS in Q3 2017 and held it in 13 quarters. The position peaked at $138K in Q4 2017. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.

CIBC Private Wealth Group reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
CIBC Private Wealth Group sold 15,335 Neos Therapeutics, Inc shares in Q1 2021, an estimated $10K.
CIBC Private Wealth Group first reported a position in Neos Therapeutics, Inc in Q3 2017 and held it in 13 quarters.
CIBC Private Wealth Group's Neos Therapeutics, Inc position peaked at $138K in Q4 2017.
0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.

Based on CIBC Private Wealth Group's 13F filing for Q1 2021, filed 12 May 2021.